PHARMACOKINETIC MODEL FOR DIAZEPAM AND ITS MAJOR METABOLITE DESMETHYLDIAZEPAM FOLLOWING DIAZEPAM ADMINISTRATION

被引：21

作者：

JACK, ML ^{[1
]}

COLBURN, WA ^{[1
]}

机构：

[1] HOFFMANN LA ROCHE INC,DEPT PHARMACOKINET & BIOPHARMACEUT,NUTLEY,NJ 07110

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1983年 / 72卷 / 11期

关键词：

D O I：

10.1002/jps.2600721120

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：1318 / 1323

页数：6

相关论文

共 24 条

[1] CHANGES IN ORAL ABSORPTION CHARACTERISTICS IN MAN OF DIPOTASSIUM CLORAZEPATE AT NORMAL AND ELEVATED GASTRIC PH
ABRUZZO, CW
MACASIEB, T
WEINFELD, R
RIDER, JA
KAPLAN, SA
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (04): : 377 - 390
[2] COMPARATIVE PROTEIN-BINDING OF DIAZEPAM AND DESMETHYLDIAZEPAM
ALLEN, MD
GREENBLATT, DJ
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (11-1) : 639 - 643
[3] CONTROLLED-STUDY OF DIAZEPAM IN PSYCHIATRIC OUTPATIENTS
BEERMAN, HM
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1964, 120 (09) : 870 - &
[4] DETERMINATION OF CHLORAZEPATE AND ITS MAJOR METABOLITES IN BLOOD AND URINE BY ELECTRON-CAPTURE GAS-LIQUID-CHROMATOGRAPHY
BROOKS, MA
HACKMAN, MR
WEINFELD, RE
MACASIEB, T
[J]. JOURNAL OF CHROMATOGRAPHY, 1977, 135 (01): : 123 - 131
[5] STEADY-STATE BIOAVAILABILITY OF 2 CLORAZEPATE DIPOTASSIUM DOSAGE FORMS
CARRIGAN, PJ
CHAO, GC
BARKER, WM
HOFFMAN, DJ
CHUN, AHC
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (01) : 18 - 28
[6] CHUN AHC, 1977, CLIN PHARMACOL THER, V22, P329
[7] COTLER S, J PHARM SCI
[8] EFFECTS AND PLASMA-LEVELS OF N-DESMETHYLDIAZEPAM AFTER ORAL-ADMINISTRATION IN NORMAL VOLUNTEERS
DASBERG, HH
[J]. PSYCHOPHARMACOLOGIA, 1975, 43 (02): : 191 - 198
[9] De Silva J A, 1970, Anal Chem, V42, P1725, DOI 10.1021/ac50160a040
[10] DIAZEPAM, A NEW TRANQUILIZER
DIFRANCESCO, A
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1963, 119 (10) : 989 - &